Introduction
Obesity, type 2 diabetes, weight loss
OBESITY, TYPE 2 DIABETES, ANORECTIC
Obesity is a complex condition associated with cognitive, affective, behavioral, cerebral, and metabolic dysfunctions [Liraglutide, a glucagon–like peptide 1 (GLP-1) receptor agonist, has been demonstrated to successfully promote weight loss. GLP-1 analogs were initially used in the treatment of patients with type 2 diabetes for their glucose–lowering effects. They have shown to have a beneficial impact on weight loss by exerting an anorectic effect [What do we know about the effects of GLP-1 receptor agonists on wanting and liking?There is evidence that GLP-1 receptor agonists affect food reward responses in patients with OB (e.g., [Schulz et al. [Here we followed Schulz et al.’s [To measure liking, we targeted the sensory pleasure during the consumption of the reward itself. As evidenced by Pool et al’s review [